{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:30:39Z","timestamp":1793817039590,"version":"4.6.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,9]],"date-time":"2015-10-09T00:00:00Z","timestamp":1444348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"RVC","award":["BB\/FO18394\/1"],"award-info":[{"award-number":["BB\/FO18394\/1"]}]},{"DOI":"10.13039\/501100000268","name":"BBSRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.vaccine.2015.10.003","type":"journal-article","created":{"date-parts":[[2015,10,24]],"date-time":"2015-10-24T19:55:58Z","timestamp":1445716558000},"page":"6199-6205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Oral application of freeze-dried yeast particles expressing the PCV2b Cap protein on their surface induce protection to subsequent PCV2b challenge in vivo"],"prefix":"10.1016","volume":"33","author":[{"given":"Robert","family":"Patterson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Eley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Browne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henny M.","family":"Martineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Werling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.10.003_bib0205","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0378-1135(99)00004-8","article-title":"Isolation and characterisation of circoviruses from pigs with wasting syndromes in Spain, Denmark and Northern Ireland","volume":"66","author":"Allan","year":"1999","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0210","doi-asserted-by":"crossref","first-page":"e91081","DOI":"10.1371\/journal.pone.0091081","article-title":"Global gene expression profiling of myeloid immune cell subsets in response to in vitro challenge with porcine circovirus 2b","volume":"9","author":"Mavrommatis","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0215","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jviromet.2009.07.028","article-title":"Heterologous expression of full-length capsid protein of porcine circovirus 2 in Escherichia coli and its potential use for detection of antibodies","volume":"162","author":"Marcekova","year":"2009","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0220","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.virusres.2011.09.041","article-title":"Efficacy and future prospects of commercially available and experimental vaccines against porcine circovirus type 2 (PCV2)","volume":"164","author":"Beach","year":"2012","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0225","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2710.1991.tb00321.x","article-title":"Oral enteric vaccines \u2013 clinical trials","volume":"16","author":"Gilligan","year":"1991","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0230","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1440-1711.2004.01214.x","article-title":"Alternative routes of mucosal immunization in large animals","volume":"82","author":"Sedgmen","year":"2004","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0235","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1016\/j.vaccine.2009.07.061","article-title":"The optimized capsid gene of porcine circovirus type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts","volume":"27","author":"Bucarey","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0240","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.prevetmed.2011.06.001","article-title":"Farm level risk factors associated with severity of post-weaning multi-systemic wasting syndrome","volume":"101","author":"Alarcon","year":"2011","journal-title":"Prev Vet Med"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0245","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.vetmic.2015.03.010","article-title":"Exposure to environmental stressors result in increased viral load and further reduction of production parameters in pigs experimentally infected with PCV2b","volume":"177","author":"Patterson","year":"2015","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0250","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1517\/14712598.5.4.565","article-title":"Yeasts encoding tumour antigens in cancer immunotherapy","volume":"5","author":"Franzusoff","year":"2005","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0255","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00164-10","article-title":"Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded beta-glucan particles","volume":"1","author":"Huang","year":"2010","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0260","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/87974","article-title":"Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity","volume":"7","author":"Stubbs","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0265","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1016\/j.vaccine.2007.04.068","article-title":"Antigenicity of infectious pancreatic necrosis virus VP2 subviral particles expressed in yeast","volume":"25","author":"Allnutt","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0270","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.vaccine.2014.01.068","article-title":"Display of Eimeria tenella EtMic2 protein on the surface of Saccharomyces cerevisiae as a potential oral vaccine against chicken coccidiosis","volume":"32","author":"Sun","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0275","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1016\/j.vaccine.2013.07.029","article-title":"Animal vaccines based on orally presented yeast recombinants","volume":"31","author":"Shin","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0280","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.vetmic.2013.06.011","article-title":"Multiple routes of porcine circovirus type 2 transmission to piglets in the presence of maternal immunity","volume":"166","author":"Dvorak","year":"2013","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0285","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/vr.100276","article-title":"Porcine circovirus type 2 infection before and during an outbreak of postweaning multisystemic wasting syndrome on a pig farm in the UK","volume":"170","author":"Wieland","year":"2012","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0290","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.dci.2011.10.009","article-title":"Yeast-surface expressed BVDV E2 protein induces a Th1\/Th2 response in naive T cells","volume":"37","author":"Patterson","year":"2012","journal-title":"Dev Comp Immunol"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0295","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1053\/rvsc.1999.0310","article-title":"DNA profiling reveals remarkably low genetic variability in a herd of SLA homozygous pigs","volume":"67","author":"Signer","year":"1999","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0300","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.rvsc.2004.04.008","article-title":"Genome sequence analysis of 10 Dutch porcine circovirus type 2 (PCV-2) isolates from a PMWS case-control study","volume":"77","author":"Grierson","year":"2004","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0305","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1128\/CVI.05318-11","article-title":"Studies on porcine circovirus type 2 vaccination of 5-day-old piglets","volume":"18","author":"O\u2019Neill","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0310","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1354\/vp.41-6-624","article-title":"Experimental reproduction of postweaning multisystemic wasting syndrome in pigs by dual infection with Mycoplasma hyopneumoniae and porcine circovirus type 2","volume":"41","author":"Opriessnig","year":"2004","journal-title":"Vet Pathol"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0315","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00262-013-1505-8","article-title":"Phase I trial of a recombinant yeast-CEA vaccine (GI-6207) in adults with metastatic CEA-expressing carcinoma","volume":"63","author":"Bilusic","year":"2014","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0320","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.vaccine.2006.10.035","article-title":"Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins","volume":"25","author":"Haller","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0325","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/lam.12188","article-title":"Oral immunization with whole yeast producing viral capsid antigen provokes a stronger humoral immune response than purified viral capsid antigen","volume":"58","author":"Kim","year":"2014","journal-title":"Lett Appl Microbiol"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0330","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1158\/0008-5472.CAN-04-1487","article-title":"Mutation-selective tumor remission with Ras-targeted, whole yeast-based immunotherapy","volume":"64","author":"Lu","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0335","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.vetimm.2012.09.001","article-title":"Evaluation of cell-mediated immune responses against porcine circovirus type 2 (PCV2) Cap and Rep proteins after vaccination with a commercial PCV2 sub-unit vaccine","volume":"150","author":"Fort","year":"2012","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0340","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2460\/ajvr.2002.63.354","article-title":"Dynamics of porcine circovirus type 2 infection in a herd of pigs with postweaning multisystemic wasting syndrome","volume":"63","author":"Rodriguez-Arrioja","year":"2002","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0345","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2460\/ajvr.2004.65.88","article-title":"Use of a polymerase chain reaction assay and an ELISA to monitor porcine circovirus type 2 infection in pigs from farms with and without postweaning multisystemic wasting syndrome","volume":"65","author":"Sibila","year":"2004","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0350","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1016\/j.vaccine.2012.04.022","article-title":"Antibody responses following vaccination versus infection in a porcine circovirus-type 2 (PCV2) disease model show distinct differences in virus neutralization and epitope recognition","volume":"30","author":"Trible","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0355","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.vetmic.2007.06.004","article-title":"Detection of neutralizing antibodies in postweaning multisystemic wasting syndrome (PMWS)-affected and non-PMWS-affected pigs","volume":"125","author":"Fort","year":"2007","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0360","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.vetimm.2008.12.024","article-title":"Development of cell-mediated immunity to porcine circovirus type 2 (PCV2) in caesarean-derived, colostrum-deprived piglets","volume":"129","author":"Fort","year":"2009","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0365","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13567-015-0157-4","article-title":"PCV2 vaccination induces IFN-gamma\/TNF-alpha co-producing T cells with a potential role in protection","volume":"46","author":"Koinig","year":"2015","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0370","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s12917-014-0286-4","article-title":"Variation in time and magnitude of immune response and viremia in experimental challenges with Porcine circovirus 2b","volume":"10","author":"Engle","year":"2015","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0375","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/age.12262","article-title":"Genome-wide analysis of TNF-alpha response in pigs challenged with porcine circovirus 2b","volume":"46","author":"Kreikemeier","year":"2015","journal-title":"Anim Genet"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0380","doi-asserted-by":"crossref","first-page":"e0115833","DOI":"10.1371\/journal.pone.0115833","article-title":"Effect of dietary selenium yeast supplementation on porcine circovirus type 2 (PCV2) infections in mice","volume":"10","author":"Liu","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0385","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.vetimm.2010.05.013","article-title":"Porcine circovirus type 2 (PCV2) Cap and Rep proteins are involved in the development of cell-mediated immunity upon PCV2 infection","volume":"137","author":"Fort","year":"2010","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0390","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tvjl.2014.02.002","article-title":"Clinical, virological, immunological and pathological evaluation of four porcine circovirus type 2 vaccines","volume":"200","author":"Seo","year":"2014","journal-title":"Vet J"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0395","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/1746-6148-8-194","article-title":"Reduction of porcine circovirus type 2 (PCV2) viremia by a reformulated inactivated chimeric PCV1-2 vaccine-induced humoral and cellular immunity after experimental PCV2 challenge","volume":"8","author":"Seo","year":"2012","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.vaccine.2015.10.003_bib0400","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.biomaterials.2013.11.073","article-title":"Targeted oral delivery of BmpB vaccine using porous PLGA microparticles coated with M cell homing peptide-coupled chitosan","volume":"35","author":"Jiang","year":"2014","journal-title":"Biomaterials"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15014115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15014115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T10:58:53Z","timestamp":1537268333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15014115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":40,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0264410X15014115"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.003","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral application of freeze-dried yeast particles expressing the PCV2b Cap protein on their surface induce protection to subsequent PCV2b challenge in vivo","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}